1. 124 AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML (>30% MARROW BLASTS) WITH MYELODYSPLASIA-RELATED CHANGES: SUBGROUP ANALYSIS OF THE AZA-AML-001 STUDY. (April 2015) Authors: Seymour, J.F.; Döhner, H.; Butrym, A.; Wierzbowska, A.; Selleslag, D.; Jang, J.H.; Cavenagh, J.D.; Kumar, R.; Schuh, A.C.; Candoni, A.; Récher, C.; Sandhu, I.; del Castillo, T. Bernal; Al-Ali, H.K.; Martinelli, G.; Falantes, J.; Nopenney, R.; Stone, R.M.; Minden, M.D.; McIntyre, H. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 96 OVERALL SURVIVAL IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML WITH >30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETICS TREATED WITH AZACITIDINE: SUBANALYSIS OF THE AZA-AML-001 STUDY. (April 2015) Authors: Döhner, H.; Seymour, J.F.; Butrym, A.; Wierzbowska, A.; Selleslag, D.; Jang, J.H.; Cavenagh, J.D.; Kumar, R.; Schuh, A.C.; Candoni, A.; Récher, C.; Sandhu, I.; del Castillo, T. Bernal; Al-Ali, H.K.; Martinelli, G.; Falantes, J.; Nopenney, R.; Stone, R.M.; Minden, M.D.; McIntyre, H. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Azacitidine Prolongs Overall Survival in Older Patients with Acute Myeloid Leukemia (AML) with Poor Prognostic Karyotypes. (April 2017) Authors: Döhner, H.; Vyas, P.; Seymour, J.F.; Santini, V.; Stone, R.M.; Minden, M.D.; Al-Ali, H.K.; del Castillo, T. Bernal; Morrill, J.; Songer, S.; Weaver, J.; Skikne, B.S.; Beach, C.L.; Dombret, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Azacitidine Versus Conventional Care Regimens (CCR) in Elderly Patients (≥75 Years) with Acute Myeloid Leukemia (AML) in the AZA-AML-001 Study. (April 2017) Authors: Seymour, J.F.; Buckstein, R.; Santini, V.; Döhner, H.; Stone, R.M.; Minden, M.D.; Kuo, C.Y.; Ben-Yehuda, D.; Bargay, J.; Songer, S.; Weaver, J.; Beach, C.L.; Dombret, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Stable Disease with Hematologic Improvement is Clinically Meaningful for Older Patients with Acute Myeloid Leukemia (AML) Treated with Azacitidine. (April 2017) Authors: Schuh, A.C.; Döhner, H.; Seymour, J.F.; Turlure, P.; Junghanss, C.; MacWhannell, A.; Tu, N.; Songer, S.; Beach, C.L.; Dombret, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Three‐dimensional rendering of otolith growth using phase contrast synchrotron tomography. Issue 5 (13th April 2016) Authors: Mapp, J. J. I.; Fisher, M. H.; Atwood, R. C.; Bell, G. D.; Greco, M. K.; Songer, S.; Hunter, E. Journal: Journal of fish biology Issue: Volume 88:Issue 5(2016) Page Start: 2075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗